| Identification | Back Directory | [Name]
Benzamide, 3,4-difluoro-N-[3-(3-methylimidazo[1,2-a]pyrimidin-2-yl)phenyl]- | [CAS]
862811-76-5 | [Synonyms]
NCGC00135472
Benzamide, 3,4-difluoro-N-[3-(3-methylimidazo[1,2-a]pyrimidin-2-yl)phenyl]- | [Molecular Formula]
C20H14F2N4O | [MOL File]
862811-76-5.mol | [Molecular Weight]
364.35 |
| Hazard Information | Back Directory | [Description]
NCGC00135472 is an gonist for human Resolvin D1 Receptor DRV1 with pro-resolving functions. | [Uses]
NCGC00135472 is a potent agonist of resolvin D1 receptor (DRV1), with the EC50 of 0.37 nM and 0.05 μM for β-arrestin and cAMP activities, respectively[1]. | [References]
[1] Nan Chiang, et al. Identification of Chemotype Agonists for Human Resolvin D1 Receptor DRV1 with Pro-Resolving Functions. Cell Chem Biol. 2019 Feb 21;26(2):244-254.e4. DOI:10.1016/j.chembiol.2018.10.023 |
|
| Company Name: |
Merck KGaA
|
| Tel: |
21-20338288 |
| Website: |
www.sigmaaldrich.cn |
|